ArticleOncology reports2016

A matrix metalloproteinase inhibitor enhances anti-cytotoxic T lymphocyte antigen-4 antibody immunotherapy in breast cancer by reprogramming the tumor microenvironment.

Mingyue Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.